HLSE:ORNBVPharmaceuticals
FDA Approval Of Tessie Puts Orion’s Animal Health Potential In Focus
Orion Oyj (HLSE:ORNBV) has received FDA approval for its proprietary veterinary drug Tessie (tasipimidine) for use in the U.S. market.
Tessie is approved as a treatment option for noise aversion and separation anxiety in dogs.
The product will be commercialized in the United States through Orion's partner Zoetis.
For Orion, known for its human pharmaceuticals and animal health products, Tessie adds a new proprietary molecule to its pet care offering at a time when spending on companion...